Nrc Health (NRC) Cumulative Dividend Pay out History TTM by Quarter, Fundamentals - CSIMarket
CSIMarket
 


Nrc Health  (NASDAQ: NRC)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

 

NRC's Dividend Pay out ratio over the 12 Months Period

Cumulative by Quarter, Trailing twelve months




Nrc Health 12 Months dividend pay out ratio, in the second quarter 2026, sequentially increased to 230.77% in the second quarter 2026, a new company high.

Within Healthcare sector 3 other companies have achieved higher 12 Months dividend pay out ratio. While in terms of ranking among all other companies, the company has moved form 4 in the first quarter 2026, to 165.


Dividend in Glossary



Cumulative Dividend Pay out Ratio II. Quarter
(Jun 30 2026)
I. Quarter
(Mar 31 2026)
IV. Quarter
(Dec 31 2025)
III. Quarter
(Sep 30 2025)
II. Quarter
(Jun 30 2025)
NRC's Pay out Ratio (TTM) 230.77 % 140.25 % 102.35 % 68.76 % 63.47 %
NRC's Dividend Pay out Ratio Total Ranking # 165 # 4 # 6 # 326 # 368

  News about Nrc Health Dividends

National Research Corporation Reports Slight Dip in Revenue for Second Quarter 2024



In a recent press release, National Research Corporation (dba NRC Health) announced its financial results for the second quarter of 2024 and shared several corporate developments. The Lincoln-based company reported a revenue of approximately $35 million for the quarter, reflecting a marginal decrease from the $36 million reported in the same quarter last year. Earnings per diluted share were $0.26, down from $0.29 in the second quarter of 2023.
Despite the slight dip in revenue and earnings, the overall financial performance of National Research Corporation remains steady. The company's net indebtedness, which is the total borrowing minus cash and cash equivalents, was not disclosed in the press release.

National Research Corporation Reports Strong Growth in Fourth Quarter and Sets New Records in Dividend Payout Ratio



National Research Corporation (NRC Health) announced its fourth-quarter and calendar year 2023 results, showcasing another consecutive quarter of growth in new sales and operating margin. The company's CEO, Michael Hays, expressed satisfaction with the momentum and highlighted the strategic trimming of non-core service lines while enhancing capabilities across the patient, customer, and employee experience continuum. One notable achievement includes setting a new high for the dividend payout ratio in the third quarter of 2023.
Factual Details:
- National Research Corporation's 12 Months dividend payout ratio sequentially rose to 137.04 in the third quarter of 2023, marking a new high for the company.
- Comparing the company's performance to peers in the Healthcare sector, it is evident that four other companies had higher 12 Months dividend payout ratios.
- Among all companies, National Research Corporation ranked at 391 in the second quarter of 2023, signifying its higher standing.


NRC's Dividend Pay out Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 0
Healthcare Sector # 4
S&P 500 # 165

Dividend Pay out Ratio Statistics
High Average Low
230.77 % 72.38 % 11.12 %
(Jun 30 2026)   (Dec 31 2013)



Other Dividend Ratios
Highest Ranking Dividend Yield
Lowest Ranking Dividend Yield
Annual Dividend Pay out for NRC
NRC's Dividend Yield




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.